Zobrazeno 1 - 10
of 132
pro vyhledávání: '"C Codina-Jané"'
Autor:
E López-Suñé, C Codina-Jané, E Calvo-Cidoncha, M Tuset-Creus, Montserrat Rodriguez-Reyes, A Soriano-Viladomiu
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Ceftolozane/tazobactam is a novel antibiotic commonly used in infections by gram-negative bacteria resistant to conventional antibiotics. Drug-dosing errors are common in patients with renal impairment and can cause adverse effects or poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75d1b827c7d5f888cda36a187b59b186
https://doi.org/10.1136/ejhpharm-2019-eahpconf.222
https://doi.org/10.1136/ejhpharm-2019-eahpconf.222
Autor:
C Codina-Jané, E. Carcelero-San Martín, G. Riu-Viladoms, G Castells-Lao, J Guell-Picazo, L Corominas-Bosch, Montserrat Rodriguez-Reyes
Publikováno v:
Eur J Hosp Pharm
Background Chemotherapy extravasation is an accidental complication of antineoplastic administration. Due to its low incidence but serious consequences, further studies are needed to achieve a better management. Purpose To analyse the context in whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee8f9077fb1ee69146e39c40d458dd79
https://europepmc.org/articles/PMC7535717/
https://europepmc.org/articles/PMC7535717/
Autor:
C. Codina Jané, J. Espaulella Panicot, N. Molist Brunet, Daniel Sevilla-Sánchez, J. Altimiras Roset, J. Amblàs Novellas, Xavier Gómez-Batiste
Publikováno v:
European Geriatric Medicine. 6:565-569
Introduction Older patients with multimorbidity usually present with progressively worse impairment, resulting in a limited life prognosis. Consequently, drug therapy, which was previously appropriate can become inappropriate and be associated with n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01805a064b1c8c18e0d8c7a680a5d829
https://doi.org/10.1016/j.eurger.2015.07.008
https://doi.org/10.1016/j.eurger.2015.07.008
Publikováno v:
Drug information and pharmacotherapy.
Background Off-label treatments are characterised as those that do not correspond to the labelled indications. They are intended to respond to the unmet medical needs of poorly studied populations or not studied at all in trials. Off-label treatments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17f21331e400ae8082f9df83bd06aaf2
https://doi.org/10.1136/ejhpharm-2017-000640.340
https://doi.org/10.1136/ejhpharm-2017-000640.340
Publikováno v:
Patient safety and risk management.
Background The World Health Organisation (WHO) updates the model list of essential medicines (MLEM) every 2 years. The list reflects the medicines that every healthcare system should have as a minimal requirement. On a global scale, elderly patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ce724e1b6c388afab5dee4188b00657
https://doi.org/10.1136/ejhpharm-2017-000640.545
https://doi.org/10.1136/ejhpharm-2017-000640.545
Autor:
E. de Puig Cabrera, P. Jolonch Santasusagna, C. Codina Jané, F. Pàez Vives, J. Gómez-Arbonés, E. Homs Peipoch, MQ Gorgas Torner, JA Schoenenberger Arnaiz, J. Camós Ramió
Publikováno v:
Farmacia Hospitalaria. 36:229-239
Objectives: To assess whether an integrated pharmaceutical care programme (IPCP) improves clinical evolution, patient quality of life, and reduces health costs in chronic patients. Material and methods: A parallel, open, and multi-centre clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c48076a6f40db39635d089ffb6c0fe3
https://doi.org/10.1016/j.farma.2011.06.015
https://doi.org/10.1016/j.farma.2011.06.015
Autor:
J. Ribas Sala, M.M. Placeres Alsina, E. López Suñé, C. Codina Jané, D. Sevilla Sánchez, M.T. Miana Mena
Publikováno v:
Farmacia Hospitalaria (English Edition). 34:9-15
Objective Description and analysis of pharmaceutical interventions for patients with parenteral nutrition and an assessment of the degree of acceptance. Method Prospective six-month study. Design of a data collection sheet (with personal data, the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3618650825692ab520df2e6b7a7ac2e
https://doi.org/10.1016/s2173-5085(10)70059-9
https://doi.org/10.1016/s2173-5085(10)70059-9
Autor:
M.M. Placeres Alsina, C. Codina Jané, E. López Suñé, M.T. Miana Mena, D. Sevilla Sánchez, J. Ribas Sala
Publikováno v:
Farmacia Hospitalaria. 34:9-15
Objective: Description and analysis of pharmaceutical interventions for patients with parenteral nutrition and an assessment of the degree of acceptance. Method: Prospective six-month study. Design of a data collection sheet (with personal data, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf6a55f733bd94e6fe088525c069d972
https://doi.org/10.1016/j.farma.2009.09.001
https://doi.org/10.1016/j.farma.2009.09.001
Autor:
C. Berga Culleré, M. Torres Gubert, M. Besalduch Martín, M. Capdevila Sunyer, E. Òdena Estradé, M.T. Vitales Farrero, MQ Gorgas Torner, J. Altimiras Ruiz, C. Codina Jané, J.R. Fernández Solà, M.T. Casajoana Cortinas, M. Tuset Creus, E. Baró Sabaté, A. Moron i Besolí, J. Serrais Benavente
Publikováno v:
Farmacia Hospitalaria. 33:312-323
Introduction: The principal objective was to determine the incidence rate of adverse drug events (ADEs) in hospitalised patients and evaluate the event prevention percentage. Methods: Multi-centre, prospective observational study lasting four months,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4dd356f0967a2c0b1bd3ff14e21cb6a
https://doi.org/10.1016/s1130-6343(09)72974-5
https://doi.org/10.1016/s1130-6343(09)72974-5
Autor:
J.A. Schönenberger-Arnaiz, M.Q. Gorgas-Torner, F. Pàez-Vives, I. Castro-Cels, C. Codina-Jané, Lourdes Pastó-Cardona, A. Clopés-Estela, C. Masuet-Aumatell, B. Bara-Oliván
Publikováno v:
Farmacia Hospitalaria (English Edition). 33:257-268
Objective To determine both the global incident, and the incident for stages of medication errors in 6 Catalonian hospitals, the types of error, and the consequences. Method A prospective design, with the global variable of the medication error. Pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::088c973c7b96613b300f3faacddde166
https://doi.org/10.1016/s2173-5085(09)70091-7
https://doi.org/10.1016/s2173-5085(09)70091-7